For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $14.77 in the prior trading day, Emergent Biosolutions Inc (NYSE: EBS) closed at $11.87, down -19.63%. In other words, the price has decreased by -$19.63 from its previous closing price. On the day, 4.23 million shares were traded. EBS stock price reached its highest trading level at $15.07 during the session, while it also had its lowest trading level at $11.5201.
Ratios:
Our goal is to gain a better understanding of EBS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 1.39 whereas as Long-Term Debt/Eq ratio is at 0.69.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 04 ’24 when Zoon Kathryn C sold 10,000 shares for $6.11 per share. The transaction valued at 61,100 led to the insider holds 54,482 shares of the business.
Zoon Kathryn C sold 1,830 shares of EBS for $8,436 on May 29 ’24. The Director now owns 64,482 shares after completing the transaction at $4.61 per share. On May 21 ’24, another insider, Zoon Kathryn C, who serves as the Director of the company, sold 1,089 shares for $5.78 each. As a result, the insider received 6,294 and left with 48,882 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 773975040 and an Enterprise Value of 1617675264. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 1.365 whereas that against EBITDA is 16.144.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $15.09, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 51.01%, while the 200-Day Moving Average is calculated to be 216.25%.
Shares Statistics:
The stock has traded on average 5.45M shares per day over the past 3-months and 2765580 shares per day over the last 10 days, according to various share statistics. A total of 52.20M shares are outstanding, with a floating share count of 50.15M. Insiders hold about 4.29% of the company’s shares, while institutions hold 68.64% stake in the company. Shares short for EBS as of 1721001600 were 4561561 with a Short Ratio of 0.84, compared to 1718323200 on 6329274. Therefore, it implies a Short% of Shares Outstanding of 4561561 and a Short% of Float of 10.66.
